Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

Data as of 4:00pm ET
 +0.04 / +0.78%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Revenue and IncomeNet Revenues0.
Depreciation And Amortization1.1K1.1K2.0K1.0K
Operating ExpensesGross Income-1.1K-1.1K-2.0K-1.0K
General Expenses1.2M1.9M1.7M1.9M
Research And Development673.3K1.1M858.0K1.3M
Total Operating Expenses1.2M1.9M1.7M1.9M
Non-Operating ExpensesOperating Income-1.2M-1.9M-1.7M-1.9M
Other Expenses-3.2K31.5K93.0K-5.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.1M-1.8M-1.6M-1.9M
Income Taxes0.000.00-4.0K0.00
Net Income-1.1M-1.8M-1.6M-1.9M
Shares To Calculate EPSShares To Calculate EPS9.1M9.9M10.1M10.1M
Shares To Calculate EPS Diluted9.1M9.9M10.1M10.1M
Earnings Per ShareEPS-$0.12-$0.18---$0.19
EPS Diluted-$0.12-$0.18-$0.16-$0.19

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.